Delta strain reduces effectiveness of COVID vaccines

Vaccines targeting the highly transmissible delta variant may now be needed, given its ability to infect people with fading immunity and potentially increased severity, researchers leading a large English study of Covid shots said, Report informs via Bloomberg.

A third wave of English cases has been driven by the delta strain among both unvaccinated people — especially those aged 12 to 24 — as well as some people who had received Covid shots, according to authors of a study of samples from about 98,000 people in England. The effectiveness of vaccines at stopping infection during the study period fell to 49%, the researchers estimated, down from 64% in a month earlier. Vaccines’ protection against development of Covid symptoms was 59%, down from 83%.

“Development of vaccines against delta may be warranted,” in the light of evidence that the strain’s spike protein has mutated to a point where antibodies raised by current shots are becoming less effective, the researchers said.

The US, UK and Israel are among the most fully vaccinated countries in the world, yet all have seen surges in Covid cases and hospitalizations linked to the delta strain. Health officials in the US have said they’re pleading with the hesitant to get immunized to try to control the spread of the virus, which has potential to lead to further, more dangerous mutations.

Despite the losses, current vaccines continue to give a relatively high degree of protection, the researchers from institutions across the UK said. Fully immunized people were three times less likely to catch delta than non-immunized peers.

The study, called React-1, looked at results of Covid testing from June 24 to July 12. The period roughly corresponds to a surge in infections across the UK as the delta variant came to fully displace the alpha strain that was first detected in the country’s south and caused last winter’s horrors.

Breakthrough infections among fully vaccinated people are becoming an increasingly important issue in countries with high vaccination rates. Such concerns still affect just a small portion of the world as only 13% of people are fully vaccinated globally, most of them in the developed world, the authors noted.